James Murphy

James Murphy has over a decade of experience in the pharmaceutical and healthcare sectors, with a focus on corporate development, transactions, and valuations within the Oncology category. Notable positions include Director of Transactions and Valuations at Pfizer, where responsibilities included executing various deals, and Senior Manager of Corporate Development, leading significant valuation assessments for mergers and acquisitions such as Biohaven Pharmaceuticals and Arena Pharmaceuticals. Prior to Pfizer, James held roles at Partners HealthCare, overseeing demand optimization projects, and interned at Sanofi, contributing to research on oncology drugs. Academic credentials include an MBA from NYU Stern School of Business and a BS in Biology from Boston College.